Literature DB >> 102477

Immune function in ankylosing spondylitics and their relatives: influence of disease and HLA B27.

F T Christiansen, B R Hawkins, R L Dawkins.   

Abstract

So as to distinguish the separate influences of ankylosing spondylitis (AS) and possible HLA B27 associated immune response genes on immune response patterns, a battery of immunological tests were performed on fourteen patients with AS and their first-degree relatives. Previously unrecognized AS was detected by clinical and radiological means. Individuals with ankylosing spondylitis had significantly higher serum IgG and IgA concentrations than both their B27 positive and B27 negative relatives. B27 positive relatives had significantly lower phytohaemagglutinin (PHA) lymphocyte transformations than B27 negative relatives (P less than 0.01), while there was no difference between the ankylosing spondylitic and B27 positive groups. Antibody titres to Streptokinase/Streptodornase were significantly higher in the B27 positive individuals, with or without AS, than their B27 negative relatives (P less than 0.005 and P less than 0.02 respectively). These results show that serum immunoglobulin differences were associated with disease, while differences in PHA stimulation and varidase antibody titres were associated with the B27 antigen. These findings may indicate the presence of HLA associated immune response genes including those involved with reactions to a particular antigenic component of Streptokinase/Streptodornase.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 102477      PMCID: PMC1537569     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  6 in total

1.  Proceedings: Evidence of impaired cell mediated immunity in the seronegative arthritides.

Authors:  R D Sturrock; K Froebel; R N MacSween; W C Dick
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

2.  Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis.

Authors:  T D Kinsella; L Espinoza; F B Vasey
Journal:  J Rheumatol       Date:  1975-09       Impact factor: 4.666

3.  Diminished mixed lymphocyte reaction in ankylosing spondylitis, relatives, and normal individuals all with HL-A 27.

Authors:  B Nikbin; D A Brewerton; D C James; J R Hobbs
Journal:  Ann Rheum Dis       Date:  1976-02       Impact factor: 19.103

4.  Chromic chloride: a coupling reagent for passive hemagglutination reactions.

Authors:  E R Gold; H H Fudenberg
Journal:  J Immunol       Date:  1967-11       Impact factor: 5.422

5.  Ankylosing spondylitis and HL-A 27.

Authors:  D A Brewerton; F D Hart; A Nicholls; M Caffrey; D C James; R D Sturrock
Journal:  Lancet       Date:  1973-04-28       Impact factor: 79.321

6.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

  6 in total
  9 in total

1.  Polyclonal B cell activation in ankylosing spondylitis.

Authors:  P Barbieri; I Olivieri; G Benedettini; P Marelli; M L Ciompi; G Pasero; M Campa
Journal:  Ann Rheum Dis       Date:  1990-06       Impact factor: 19.103

Review 2.  Immune functions and inflammatory reactions in HLA-B27 positive subjects.

Authors:  R Tertti; P Toivanen
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

Review 3.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

4.  Antibody producing capacity to the bacteriophage phi X174 in yersinia arthritis.

Authors:  R Bucknall; M Leirisalo-Repo; O Laitinen; J V Jones
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

5.  Polymorphonuclear cell motility, ankylosing spondylitis, and HLA B27.

Authors:  C T Pease; J N Fordham; H L Currey
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

6.  Secretory IgA: immune defence pattern in ankylosing spondylitis and klebsiella.

Authors:  M Calguneri; L Swinburne; R Shinebaum; E M Cooke; V Wright
Journal:  Ann Rheum Dis       Date:  1981-12       Impact factor: 19.103

7.  Immunological variables and acute-phase reactants in patients with ankylosing spondylitis (Bechterew's syndrome) and their relatives.

Authors:  O Vinje; P Møller; J Mellbye
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

8.  Depressed lymphocyte transformation by yersinia and Escherichia coli in yersinia arthritis.

Authors:  R Leino; R Vuento; S Koskimies; M Viander; A Toivanen
Journal:  Ann Rheum Dis       Date:  1983-04       Impact factor: 19.103

9.  Ankylosing spondylitis and monoclonal gammopathies.

Authors:  G Renier; J C Renier; M Gardembas-Pain; A Chevailler; M Boasson; D Hurez
Journal:  Ann Rheum Dis       Date:  1992-08       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.